as 12-03-2024 12:34pm EST
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
Founded: | 1970 | Country: | United States |
Employees: | N/A | City: | CINCINNATI |
Market Cap: | 8.6B | IPO Year: | N/A |
Target Price: | $641.50 | AVG Volume (30 days): | 89.8K |
Analyst Decision: | Buy | Number of Analysts: | 2 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 19.78 | EPS Growth: | 22.57 |
52 Week Low/High: | $523.33 - $654.62 | Next Earning Date: | 10-29-2024 |
Revenue: | $2,377,206,000 | Revenue Growth: | 6.83% |
Revenue Growth (this year): | 8.28% | Revenue Growth (next year): | 7.06% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
LEE SPENCER S | CHE | executive vice president | Nov 27 '24 | Sell | $575.62 | 732 | $421,356.04 | 18,287 | |
MCNAMARA KEVIN J | CHE | president and CEO | Nov 25 '24 | Sell | $572.77 | 2,000 | $1,145,540.00 | 101,735 | |
LEE SPENCER S | CHE | executive vice president | Nov 22 '24 | Sell | $565.71 | 1,000 | $565,710.00 | 18,287 | |
MCNAMARA KEVIN J | CHE | president and CEO | Sep 26 '24 | Sell | $598.81 | 2,000 | $1,197,620.00 | 101,735 | |
WALSH GEORGE J III | CHE | Director | Sep 26 '24 | Sell | $597.47 | 400 | $238,988.00 | 3,046 | |
Westfall Nicholas Michael | CHE | Executive Vice President | Sep 9 '24 | Sell | $569.35 | 1,713 | $975,296.55 | 6,109 |
CHE Breaking Stock News: Dive into CHE Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
MT Newswires
4 days ago
Insider Monkey
5 days ago
Argus Research
7 days ago
Zacks
8 days ago
MT Newswires
11 days ago
Zacks
11 days ago
Argus Research
21 days ago
The information presented on this page, "CHE Chemed Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.